NCT02768441View on ClinicalTrials.gov

Dexamphetamine Sustained Release Pharmacokinetics and Clinical Validation of Dried Blood Spots

EARLY_PHASE1CompletedINTERVENTIONAL
Enrollment

12

Participants

Timeline

Start Date

November 1, 2016

Primary Completion Date

June 1, 2017

Study Completion Date

June 1, 2017

Conditions
Cocaine Addiction
Interventions
DRUG

Dexamphetamine

Participants will receive 60 mg Dexamphetamine SR daily for 5 consecutive days

Trial Locations (1)

Unknown

AMC, Amsterdam

All Listed Sponsors
lead

The Netherlands Cancer Institute

OTHER

NCT02768441 - Dexamphetamine Sustained Release Pharmacokinetics and Clinical Validation of Dried Blood Spots | Biotech Hunter | Biotech Hunter